BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 36575480)

  • 1. Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures.
    Cui Y; Li Z; Xiang M; Han D; Yin Y; Ma C
    Radiat Oncol; 2022 Dec; 17(1):212. PubMed ID: 36575480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
    Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT radiomics features of meso-esophageal fat in predicting overall survival of patients with locally advanced esophageal squamous cell carcinoma treated by definitive chemoradiotherapy.
    Yan S; Li FP; Jian L; Zhu HT; Zhao B; Li XT; Shi YJ; Sun YS
    BMC Cancer; 2023 May; 23(1):477. PubMed ID: 37231388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A machine learning approach using
    Qi WX; Li S; Xiao J; Li H; Chen J; Zhao S
    Front Immunol; 2024; 15():1351750. PubMed ID: 38352868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a
    Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
    BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computed tomography-based deep-learning prediction of neoadjuvant chemoradiotherapy treatment response in esophageal squamous cell carcinoma.
    Hu Y; Xie C; Yang H; Ho JWK; Wen J; Han L; Lam KO; Wong IYH; Law SYK; Chiu KWH; Vardhanabhuti V; Fu J
    Radiother Oncol; 2021 Jan; 154():6-13. PubMed ID: 32941954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel CT-based radiomics model for predicting response and prognosis of chemoradiotherapy in esophageal squamous cell carcinoma.
    Kasai A; Miyoshi J; Sato Y; Okamoto K; Miyamoto H; Kawanaka T; Tonoiso C; Harada M; Goto M; Yoshida T; Haga A; Takayama T
    Sci Rep; 2024 Jan; 14(1):2039. PubMed ID: 38263395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of MRI-based radiomics signatures models for prediction of disease-free survival and overall survival in patients with esophageal squamous cell carcinoma.
    Chu F; Liu Y; Liu Q; Li W; Jia Z; Wang C; Wang Z; Lu S; Li P; Zhang Y; Liao Y; Xu M; Yao X; Wang S; Liu C; Zhang H; Wang S; Yan X; Kamel IR; Sun H; Yang G; Zhang Y; Qu J
    Eur Radiol; 2022 Sep; 32(9):5930-5942. PubMed ID: 35384460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy.
    Guo L; Liu A; Geng X; Zhao Z; Nie Y; Wang L; Liu D; Li Y; Li Y; Li D; Wang Q; Li Z; Liu X; Li M
    Thorac Cancer; 2024 Apr; 15(12):947-964. PubMed ID: 38480505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning model based on enhanced CT radiomics for the preoperative prediction of lymphovascular invasion in esophageal squamous cell carcinoma.
    Wang Y; Bai G; Huang M; Chen W
    Front Oncol; 2024; 14():1308317. PubMed ID: 38549935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer.
    Luo HS; Chen YY; Huang WZ; Wu SX; Huang SF; Xu HY; Xue RL; Du ZS; Li XY; Lin LX; Huang HC
    Radiat Oncol; 2021 Oct; 16(1):201. PubMed ID: 34641928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computed tomography-based radiomics analysis to predict lymphovascular invasion in esophageal squamous cell carcinoma.
    Peng H; Yang Q; Xue T; Chen Q; Li M; Duan S; Cai B; Feng F
    Br J Radiol; 2022 Feb; 95(1130):20210918. PubMed ID: 34908477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative CT radiomics of esophageal squamous cell carcinoma and lymph node to predict nodal disease with a high diagnostic capability.
    Wu YP; Wu L; Ou J; Cao JM; Fu MY; Chen TW; Ouchi E; Hu J
    Eur J Radiol; 2024 Jan; 170():111197. PubMed ID: 37992611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishing a survival prediction model for esophageal squamous cell carcinoma based on CT and histopathological images.
    Wang J; Wu LL; Zhang Y; Ma G; Lu Y
    Phys Med Biol; 2021 Jul; 66(14):. PubMed ID: 34192686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting response to CCRT for esophageal squamous carcinoma by a radiomics-clinical SHAP model.
    Cheng X; Zhang Y; Zhu M; Sun R; Liu L; Li X
    BMC Med Imaging; 2023 Oct; 23(1):145. PubMed ID: 37779188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential value of CT-based comprehensive nomogram in predicting occult lymph node metastasis of esophageal squamous cell paralaryngeal nerves: a two-center study.
    Xue T; Wan X; Zhou T; Zou Q; Ma C; Chen J
    J Transl Med; 2024 Apr; 22(1):399. PubMed ID: 38689366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model integrating CT-based radiomics and genomics for survival prediction in esophageal cancer patients receiving definitive chemoradiotherapy.
    Cui J; Li L; Liu N; Hou W; Dong Y; Yang F; Zhu S; Li J; Yuan S
    Biomark Res; 2023 Apr; 11(1):44. PubMed ID: 37095586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics Analysis of PET and CT Components of
    Wang X; Lu Z
    Front Oncol; 2021; 11():638124. PubMed ID: 33928029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiomics and dosiomics for predicting complete response to definitive chemoradiotherapy patients with oesophageal squamous cell cancer using the hybrid institution model.
    Kawahara D; Murakami Y; Awane S; Emoto Y; Iwashita K; Kubota H; Sasaki R; Nagata Y
    Eur Radiol; 2024 Feb; 34(2):1200-1209. PubMed ID: 37589902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
    Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
    World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.